Flyer

Archives of Clinical Microbiology

  • ISSN: 1989-8436
  • Journal h-index: 24
  • Journal CiteScore: 8.01
  • Journal Impact Factor: 7.55
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • The Global Impact Factor (GIF)
  • Open Archive Initiative
  • China National Knowledge Infrastructure (CNKI)
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Proquest Summons
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • Scimago Journal Ranking
  • Secret Search Engine Labs
  • ResearchGate
  • International Committee of Medical Journal Editors (ICMJE)
Share This Page

Mini Review - (2023) Volume 14, Issue 4

A Review on Hepatitis Virus

Dr. Vishal Kumar*
 
Department of Virology Bioscience and technology, University of Ramashavrup Biotechnology, India
 
*Correspondence: Dr. Vishal Kumar, Department of Virology Bioscience and technology, University of Ramashavrup Biotechnology, India, Email:

Received: 03-Jul-2023, Manuscript No. ipacm-23-13690; Editor assigned: 05-Jul-2023, Pre QC No. ipacm-23-13690 (PQ); Reviewed: 19-Jul-2023, QC No. ipacm-23-13690; Revised: 24-Jul-2023, Manuscript No. ipacm-23-13690 (R); Published: 29-Jul-2023

Abstract

Hepatitis refers to an inflammation of the liver, which can be caused by a range of factors, including viruses, alcohol abuse, and certain medications. Viral hepatitis is a group of diseases caused by different viruses, including hepatitis A, B, C, D, and E. These viruses can lead to acute and chronic liver disease, liver cancer, and even death. Hepatitis A is transmitted through contaminated food and water or close contact with an infected person. The symptoms of hepatitis A include fever, fatigue, and loss of appetite, nausea, and jaundice. Most people recover from hepatitis A within a few weeks with no long-term effects, and there is a safe and effective vaccine available to prevent infection. Hepatitis viruses are a group of highly infectious and potentially lifethreatening viruses that attack the liver and cause inflammation. There are five main types of hepatitis viruses: A, B, C, D, and E. Each type of hepatitis virus has different modes of transmission, clinical features, and outcomes. Hepatitis A and E are primarily transmitted through contaminated food or water, while hepatitis B, C, and D are transmitted through blood and body fluids. Hepatitis A is typically a self-limiting disease, and most people recover without any complications. Hepatitis B, C, and D, on the other hand, can cause chronic infection, which can lead to liver cirrhosis, liver failure, and liver cancer. Hepatitis B is preventable through vaccination, while hepatitis C can be cured with antiviral therapy. There is currently no cure for hepatitis D, but treatment is available to manage symptoms and slow disease progression.

Keywords

Viral hepatitis; Blood and body fluids; Hepatitis A and E; Hepatitis B & C & D; Liver disease; Liver cancer

INTRODUCTION

Hepatitis B is spread through infected blood and bodily fluids, including sexual contact and the sharing of needles or razors. It can also be passed from an infected mother to her new-born during childbirth. The symptoms of hepatitis B are similar to those of hepatitis A, but the infection can lead to chronic liver disease and liver cancer if left untreated [1]. A vaccine is available to prevent hepatitis B, and antiviral medications can help manage chronic infections. Hepatitis C is spread through contaminated blood, primarily through sharing needles or other injection equipment. It can also be passed through sexual contact, although this is less common. Most people with hepatitis C have no symptoms until the infection has progressed to advanced liver disease, which can include cirrhosis and liver cancer [2]. There is no vaccine for hepatitis C, but antiviral medications can cure the infection in most people. Hepatitis D only occurs in people who are already infected with hepatitis B. It is spread through the same means as hepatitis B, and it can lead to more severe liver disease than hepatitis B alone. The hepatitis B vaccine also provides protection against hepatitis D. Hepatitis E is spread through contaminated food and water, particularly in developing countries with poor sanitation [3]. It is usually a self-limiting infection, similar to hepatitis A, but it can cause severe liver disease in pregnant women. There is no vaccine for hepatitis E, but the infection can be prevented through improved sanitation and hygiene practices.

The diagnosis of hepatitis is based on clinical presentation, laboratory tests, and imaging studies [4]. Patients with acute hepatitis typically present with flu-like symptoms, jaundice, abdominal pain, and fatigue. Chronic hepatitis may be asymptomatic for many years, and liver function tests and viral load tests are used to monitor disease activity and guide treatment decisions [5]. Prevention of hepatitis virus infections is key to reducing the global burden of liver disease. This includes measures such as vaccination, safe injection practices, and practicing safe sex. Health education and awareness campaigns are also essential to promote prevention and early diagnosis [6]. Hepatitis is a serious inflammatory disease that affects the liver and can be caused by a range of viral infections. Hepatitis viruses are a group of viruses that can cause this inflammation and damage to the liver. There are several types of hepatitis viruses, each with its unique properties and modes of transmission.

Hepatitis viruses are among the most common causes of liver disease worldwide [7]. They can lead to both acute and chronic infections that can be mild, severe, or even fatal. Hepatitis A, B, C, D, and E viruses are the most common types of hepatitis viruses that affect humans. Hepatitis A virus (HAV) is transmitted through contaminated food and water or through close contact with an infected person [8]. It typically causes a short-term, acute infection, which can be severe in some cases, but it usually resolves within a few weeks without treatment. Hepatitis B virus (HBV) is transmitted through blood, semen, or other body fluids of an infected person. It can lead to both acute and chronic infections, which can cause liver damage, cirrhosis, and liver cancer. It is preventable through vaccination [9].

Hepatitis C virus (HCV) is also transmitted through blood and can cause both acute and chronic infections, which can lead to liver damage and liver cancer. There is no vaccine for HCV, but new treatments have been developed that can cure the infection in most cases. Hepatitis D virus (HDV) is a rare type of hepatitis virus that only affects people who already have HBV. It can cause severe liver damage and is considered the most severe form of viral hepatitis. Hepatitis E virus (HEV) is transmitted through contaminated food and water and is most common in developing countries [10]. It typically causes a short-term, acute infection, but can be severe in pregnant women and people with weakened immune systems.

CONCLUSION

Viral hepatitis is a serious and potentially life-threatening illness that affects millions of people worldwide. Prevention and early detection are key to reducing the impact of hepatitis on public health. Vaccines are available to prevent hepatitis A and B, and antiviral medications can cure or manage chronic infections of hepatitis B and C. It is important to practice safe sex, avoid sharing needles or other injection equipment, and maintain good hygiene and sanitation practices to reduce the risk of contracting hepatitis. If you suspect you may have been exposed to hepatitis or are experiencing symptoms of liver disease, seek medical attention promptly. Hepatitis viruses are a significant public health concern worldwide. They can cause a range of liver diseases, from mild to severe, and can be transmitted through various routes. Prevention through vaccination, safe sex practices, and avoiding risky behaviours is crucial in reducing the spread of these viruses. Early diagnosis and treatment can also help prevent complications and improve outcomes for those affected by these viruses. Hepatitis viruses are a significant public health concern worldwide. Understanding the modes of transmission, clinical features, and outcomes of each type of hepatitis virus is crucial for effective prevention, diagnosis, and management of these infections. Continued efforts are needed to improve access to prevention and treatment strategies, reduce the global burden of liver disease, and ultimately eliminate viral hepatitis as a public health threat. Hepatitis viruses are a group of infectious agents that primarily target the liver, causing inflammation and potentially leading to severe liver damage, liver cancer, and other complications. There are several types of hepatitis viruses, including hepatitis A, B, C, D, and E, each with different transmission routes, clinical manifestations, and treatment options. Although the development of vaccines and antiviral therapies has significantly reduced the burden of hepatitis infections, hepatitis viruses remain a significant public health concern, particularly in developing countries where access to healthcare and prevention measures may be limited. Prevention strategies, such as vaccination, safe injection practices, and safe sex, are essential for reducing the transmission of hepatitis viruses. Early diagnosis, appropriate medical care, and lifestyle changes, such as abstaining from alcohol and adopting a healthy diet, can also help prevent or delay the progression of liver disease in people with hepatitis infections. Raising awareness about hepatitis viruses and promoting preventive measures, coupled with improving access to affordable and effective treatments, will be critical in controlling and ultimately eliminating hepatitis infections and their associated health consequences.

REFERENCES

  1. Sehgal M, Ladd HJ, Totapally B, et al. Trends in Epidemiology and Microbiology of Severe Sepsis and Septic Shock in Children. Hospital Pediatrics. 2020;10: 1021-1030.
  2. Indexed at, Google Scholar, Crossref

  3. Song G, Liang G, Liu W, et al. Fungal Co-infections Associated with Global COVID-19 Pandemic: A Clinical and Diagnostic Perspective from China. Mycopathologia. 2020;185: 599-606.
  4. Indexed at, Google Scholar, Crossref

  5. Nwokolo NC, Boag FC. Chronic vaginal candidiasis Management in the postmenopausal patient. Drugs & Aging. 2000;16: 335-9.
  6. Indexed at, Google scholar Crossref

  7. Akpan A, Morgan R. Oral candidiasis. Postgrad Med J. 2002;78: 455-459.
  8. Google Scholar, Crossref

  9. Lippi D, Gotuzzo E. the greatest steps towards the discovery of Vibrio cholerae. Clin Microbiol Infect. 2014;20: 191-195.
  10. Indexed at, Google Scholar, Crossref

  11. Cassells AC. Pathogen and biological contamination management in plant tissue culture: phytopathogens, vitro pathogens, and vitro pests. Plant Cell Culture Protocols. Methods mol Boil. 2012;877: 57-80.
  12. Indexed at, Google Scholar, Crossref

  13. Belland R, Ouellette S, Gieffers J, et al. Chlamydia pneumoniae and atherosclerosis. Cell Microbiol. 2004;6: 117-127.
  14. Indexed at, Google Scholar, Crossref

  15. Azoulay E, Russell L, Van de Louw A,et al. Diagnosis of severe respiratory infections in immunocompromised patients. Intensive Care Medicine. 2020;46: 298-314.
  16. Indexed at, Google Scholar, Crossref

  17. Stevenson TH, Castillo A, Lucia LM, et al. Growth of Helicobacter pylori in various liquid and plating media. Lett Appl Microbiol. 2000;30: 192-196.
  18. Indexed at, Google Scholar, Crossref

  19. Viale P, Giannella M, Bartoletti M,et al. Considerations About Antimicrobial Stewardship in Settings with Epidemic Extended-Spectrum β-Lactamase-Producing or Carbapenem-Resistant Enterobacteriaceae. Infect Dis Ther. 2015;4: 65-83.
  20. Indexed at, Google Scholar, Crossref